Regencell Bioscience Holdings Ltd Free Cash Flow Margin 1 year YoY Change (%) is 13,548.73% for the Trailing 12 Months (TTM) ending September 30, 2022, a 9,558.56% change year over year. The Free Cash Flow Margin measures the percentage of revenue that is converted into free cash flow. It indicates the company's ability to generate cash flow from its operations after accounting for capital expenditures. A higher margin suggests better cash flow generation and potential for reinvestment or distribution to shareholders. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.